PACS
PACS Group, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R Mar 5 PACS Group appointed Dr. Patrick Conway, former CMS Deputy Administr…
- S Aug 17 to Aug 21 5 days of insider sells: $16.6M by 1 insider, avg $44.11
- S Sep 1 to Sep 16 11 days of insider sells: $20.8M by 3 insiders, avg $43.36
- S Oct 1 to Oct 21 11 days of insider sells: $14.7M by 2 insiders, avg $45.16
Signal stack
Where each data set points today.
- InsidersMIXED
3 insiders sold $52.1M. Excludes 3 subscriber-only trades.
- InstitutionsBULLISH
Q2 2026: 30 added (1 new), 12 trimmed or exited. Largest new: Clark Capital Management Group, $11.3M.
- AnalystsBULLISH
11 of 12 rate it Buy or better. Every target is above the price.
- TrendUPTREND
11% above its 50-day average. New closing high $48.76 on Oct 26.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| AMERICAN CENTURY COMPANIES INC | ADD | $132.5M |
| AMERIPRISE FINANCIAL INC | ADD | $85.1M |
| Alyeska Investment Group, L.P. | TRIM | $65.6M |
| DIMENSIONAL FUND ADVISORS LP | ADD | $52.5M |
| JANE STREET GROUP, LLC | ADD | $24.9M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | $18.3M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | TRIM | $12.9M |
| FIRST TRUST ADVISORS LP | DOUBLED | $12.7M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
12 analystsPrice is below the lowest target. Median implies +21%.Targets as of Oct 27, 2026.
| Date | Firm | Rating |
|---|---|---|
| Sep 4, 2026 | JP Morgan MAINTAIN | Overweight |
| Aug 10, 2026 | Oppenheimer MAINTAIN | Outperform |
| Aug 6, 2026 | UBS MAINTAIN | Buy |
| Aug 6, 2026 | RBC Capital MAINTAIN | Outperform |
| Aug 6, 2026 | Truist Securities MAINTAIN | Buy |
| Jul 8, 2026 | UBS MAINTAIN | Buy |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 23, 2026 | 🔒 Fresh data, subscribers only | SELL | |
| Oct 23, 2026 | 🔒 Fresh data, subscribers only | SELL | |
| Oct 22, 2026 | 🔒 Fresh data, subscribers only | SELL | |
| Oct 21, 2026 | Murray Jason Hulse Co-Founder, CEO & Chairman | SELL | $314.8K |
| Oct 20, 2026 | Murray Jason Hulse Co-Founder, CEO & Chairman | SELL | $1.8M |
| Oct 19, 2026 | Murray Jason Hulse Co-Founder, CEO & Chairman | SELL | $77.1K |
| Oct 16, 2026 | Murray Jason Hulse Co-Founder, CEO & Chairman | SELL | $402.9K |
| Oct 15, 2026 | Murray Jason Hulse Co-Founder, CEO & Chairman | SELL | $211.3K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 15, 2026SecBot reports
17 filings · 1 bullish · 5 bearish · 1 mixed · 10 neutral- BEARISH CLUSTEROct 21, 2026
PACS Group insiders, including CEO Jason Hulse and President Joshua Jergensen, sold a combined…
The CEO's concentrated open-market selling without a 10b5-1 plan suggests potential negative non-public information. Monitor for upcoming earnings or operational updates that could explain the…
- NEUTRAL CLUSTEROct 16, 2026
PACS Group CEO Jason Hulse sold ~$5.6M in open-market shares over a 3-day window (Oct 14-16), and…
Monitor for any subsequent Form 4 filings or 8-Ks that might explain the concentrated selling — such as a secondary offering, lockup expiration, or personal liquidity needs. The absence of a 10b5-1…
- BEARISH CLUSTERSep 17, 2026
Three PACS insiders — the President & COO, a Director/10% Owner, and the CEO/Chairman — sold a…
The COO and a Director/10% Owner both sold significant open-market positions without a 10b5-1 plan, suggesting potential concern about near-term valuation or fundamentals. Monitor for upcoming…
- BEARISH CLUSTERSep 15, 2026
Two PACS insiders — Director/10% Owner Mark Hancock and Co-Founder/CEO Jason Murray — sold a…
Monitor for any upcoming corporate announcements or earnings that may have prompted this concentrated selling. The director's $13M divestiture is the dominant signal — watch for further insider…
All PACS filing & press-release reports (17)
- CLUSTER reportOct 21, 2026
- CLUSTER reportOct 16, 2026
- CLUSTER reportSep 17, 2026
- CLUSTER reportSep 15, 2026
- CLUSTER reportAug 27, 2026
- CLUSTER reportAug 19, 2026
- CLUSTER reportJul 16, 2026
- CLUSTER reportJul 10, 2026
- CLUSTER reportJul 6, 2026
- CLUSTER reportJun 26, 2026
- INST-CLUSTER reportJun 11, 2026
- INST-CLUSTER reportJun 11, 2026
- 144 reportMay 15, 2026
- DEFA14A reportApr 28, 2026
- 3 reportApr 27, 2026
- 8-K reportApr 27, 2026
- 8-K reportMar 5, 2026